1. Home
  2. LQDT vs ARVN Comparison

LQDT vs ARVN Comparison

Compare LQDT & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

HOLD

Current Price

$30.87

Market Cap

859.6M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$12.35

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDT
ARVN
Founded
1999
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
859.6M
781.0M
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
LQDT
ARVN
Price
$30.87
$12.35
Analyst Decision
Buy
Buy
Analyst Count
1
23
Target Price
$40.00
$18.14
AVG Volume (30 Days)
177.0K
846.9K
Earning Date
02-05-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
38.09
N/A
EPS
0.87
N/A
Revenue
$476,669,000.00
$312,300,000.00
Revenue This Year
N/A
$11.17
Revenue Next Year
N/A
N/A
P/E Ratio
$35.56
N/A
Revenue Growth
31.20
93.86
52 Week Low
$21.67
$5.90
52 Week High
$39.72
$20.63

Technical Indicators

Market Signals
Indicator
LQDT
ARVN
Relative Strength Index (RSI) 55.79 55.88
Support Level $29.11 $11.01
Resistance Level $32.18 $12.74
Average True Range (ATR) 0.83 0.53
MACD -0.30 -0.07
Stochastic Oscillator 56.68 78.10

Price Performance

Historical Comparison
LQDT
ARVN

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: